Early Screening for Diabetic Retinopathy in Newly Diagnosed Type 2 Diabetes and Its Effectiveness in Terms of Morbidity and Clinical Treatment: A Nationwide Population-Based Cohort

Frontiers in Public Health

article

Yu-Chien Chung¹  Ting Xu⁴  Tao-Hsin Tung⁵  Mingchih Chen²  Pei-En Chen⁷ 

[1] Department of Ophthalmology, Fu Jen Catholic University Hospital, Fu Jen Catholic University;Graduate Institute of Business Administration, Fu Jen Catholic University;School of Medicine, Fu Jen Catholic University;Department Endocrinology and Metabolism, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University;Evidence-Based Medicine Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University;Artificial Intelligence Development Center, Fu Jen Catholic University;Institute of Health Policy and Management, National Taiwan University;Taiwan Association of Health Industry Management and Development

关键词: newly diagnosed diabetes;    type 2 diabetes mellitus;    diabetic retinopathy;    screen;    ophthalmology;   

DOI  :  10.3389/fpubh.2022.771862

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

Purpose To characterize the association between the frequency of screening for diabetic retinopathy (DR) and the detection of DR in patients with newly diagnosed type 2 diabetes mellitus (T2DM). Methods This nationwide population-based cohort study used data from the National Health Insurance Research Database to identify adult patients who were newly diagnosed with T2DM between 2000 and 2004. Data from their follow-up Diabetic retinopathy (DR) treatments over the next 10 years following diagnosis were also analyzed. Results The 41,522 subjects were respectively assigned to a periodic screening group ( n = 3850) and nonperiodic screening group ( n = 37,672). Significant differences were observed between the two groups in terms of age, Charlson Comorbidity Index (CCI), sex, DR treatment, and the prevalence of DR. The association between periodic screening and DR treatment, only the elderly, female, and patient with severe CCI status showed the significance in the further stratified analysis. Conclusion Periodic screening (annual or biannual screening in the first 5 years) was more effective than nonperiodic screening in detecting instances of DR in the middle-to-advanced aged group but not among younger patients. Screening pattern did not have a significant effect on the likelihood of DR-related treatment during the 5-year follow-up. It appears that a tight screening schedule for the first 5 years after diagnosis with diabetes is not necessary.

【 授权许可】

CC BY